Ovarian cancer vaccine targeting a retired protein receives Canadian patent support
A vaccine aimed at a previously dismissed protein for ovarian cancer has secured backing for a patent in Canada, according to Stock Titan.
A vaccine aimed at a previously dismissed protein for ovarian cancer has secured backing for a patent in Canada, according to Stock Titan.